ENDO INTERNATIONAL PLC (ENDP) Fundamental Analysis & Valuation

NASDAQ:ENDP • IE00BJ3V9050

0.2926 USD
-0.02 (-5%)
At close: Aug 25, 2022
0.26 USD
-0.03 (-11.14%)
After Hours: 8/25/2022, 10:28:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ENDP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, ENDP scores 1 out of 10 in our fundamental rating. ENDP was compared to 193 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of ENDP have multiple concerns. ENDP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. ENDP Profitability Analysis

1.1 Basic Checks

  • In the past year ENDP was profitable.
ENDP Yearly Net Income VS EBIT VS OCF VS FCFENDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -1B -2B -3B

1.2 Ratios

Industry RankSector Rank
ROA -40.81%
ROE N/A
ROIC 8.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENDP Yearly ROA, ROE, ROICENDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 -200 -400

1.3 Margins

Industry RankSector Rank
OM 19.02%
PM (TTM) -93.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ENDP Yearly Profit, Operating, Gross MarginsENDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ENDP Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ENDP is still creating some value.
  • Compared to 1 year ago, ENDP has more shares outstanding
  • Compared to 1 year ago, ENDP has a worse debt to assets ratio.
ENDP Yearly Shares OutstandingENDP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
ENDP Yearly Total Debt VS Total AssetsENDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5B 10B

2.2 Solvency

  • ENDP has an Altman-Z score of -3.02. This is a bad value and indicates that ENDP is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of -2.52 indicates that ENDP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -2.52
Debt/FCF N/A
Altman-Z -3.02
ROIC/WACC1.22
WACC6.62%
ENDP Yearly LT Debt VS Equity VS FCFENDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.86 indicates that ENDP should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.62 indicates that ENDP should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.62
ENDP Yearly Current Assets VS Current LiabilitesENDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ENDP Growth Analysis

3.1 Past

  • The earnings per share for ENDP have decreased strongly by -12.08% in the last year.
  • ENDP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.54% yearly.
  • Looking at the last year, ENDP shows a decrease in Revenue. The Revenue has decreased by -1.56% in the last year.
  • Measured over the past years, ENDP shows a decrease in Revenue. The Revenue has been decreasing by -5.68% on average per year.
EPS 1Y (TTM)-12.08%
EPS 3Y1.48%
EPS 5Y-8.54%
EPS Q2Q%-95.38%
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y0.52%
Revenue growth 5Y-5.68%
Sales Q2Q%-20.27%

3.2 Future

  • ENDP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -34.53% yearly.
  • ENDP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.13% yearly.
EPS Next Y-57.56%
EPS Next 2Y-45.48%
EPS Next 3Y-38.91%
EPS Next 5Y-34.53%
Revenue Next Year-18.43%
Revenue Next 2Y-12.85%
Revenue Next 3Y-9.64%
Revenue Next 5Y-8.13%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ENDP Yearly Revenue VS EstimatesENDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
ENDP Yearly EPS VS EstimatesENDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. ENDP Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 0.13, the valuation of ENDP can be described as very cheap.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, ENDP is valued rather cheaply.
  • A Price/Forward Earnings ratio of 0.33 indicates a rather cheap valuation of ENDP.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, ENDP is valued rather cheaply.
Industry RankSector Rank
PE 0.13
Fwd PE 0.33
ENDP Price Earnings VS Forward Price EarningsENDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.29
ENDP Per share dataENDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • A cheap valuation may be justified as ENDP's earnings are expected to decrease with -38.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.48%
EPS Next 3Y-38.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ENDP Dividend Analysis

5.1 Amount

  • No dividends for ENDP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ENDP Fundamentals: All Metrics, Ratios and Statistics

ENDO INTERNATIONAL PLC

NASDAQ:ENDP (8/25/2022, 10:28:44 PM)

After market: 0.26 -0.03 (-11.14%)

0.2926

-0.02 (-5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-09
Earnings (Next)11-07
Inst Owners0%
Inst Owner Change0%
Ins Owners2.12%
Ins Owner Change0%
Market Cap68.80M
Revenue(TTM)2.78B
Net Income(TTM)-2.60B
Analysts42.86
Price Target1.02 (248.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.13
Fwd PE 0.33
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.29
EPS(TTM)2.33
EY796.31%
EPS(NY)0.9
Fwd EY306.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.83
BVpS-13.6
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.81%
ROE N/A
ROCE N/A
ROIC 8.07%
ROICexc N/A
ROICexgc 26.18%
OM 19.02%
PM (TTM) -93.31%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity -2.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.62
Altman-Z -3.02
F-Score5
WACC6.62%
ROIC/WACC1.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.08%
EPS 3Y1.48%
EPS 5Y-8.54%
EPS Q2Q%-95.38%
EPS Next Y-57.56%
EPS Next 2Y-45.48%
EPS Next 3Y-38.91%
EPS Next 5Y-34.53%
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y0.52%
Revenue growth 5Y-5.68%
Sales Q2Q%-20.27%
Revenue Next Year-18.43%
Revenue Next 2Y-12.85%
Revenue Next 3Y-9.64%
Revenue Next 5Y-8.13%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ENDO INTERNATIONAL PLC / ENDP FAQ

Can you provide the ChartMill fundamental rating for ENDO INTERNATIONAL PLC?

ChartMill assigns a fundamental rating of 2 / 10 to ENDP.


What is the valuation status of ENDO INTERNATIONAL PLC (ENDP) stock?

ChartMill assigns a valuation rating of 6 / 10 to ENDO INTERNATIONAL PLC (ENDP). This can be considered as Fairly Valued.


Can you provide the profitability details for ENDO INTERNATIONAL PLC?

ENDO INTERNATIONAL PLC (ENDP) has a profitability rating of 3 / 10.


What is the valuation of ENDO INTERNATIONAL PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ENDO INTERNATIONAL PLC (ENDP) is 0.13 and the Price/Book (PB) ratio is -0.02.


Can you provide the financial health for ENDP stock?

The financial health rating of ENDO INTERNATIONAL PLC (ENDP) is 2 / 10.